Results 151 to 160 of about 4,156,285 (177)
Some of the next articles are maybe not open access.
A simple and rapid test for Pivka-II in plasma
Thrombosis Research, 1982A simple and rapid assay for the detection of PIVKA-II is described. The principle of the assay is based on agglutination of antihuman prothrombin rabbit IgG coated latex with absorbed plasma which is treated with barium carbonate. This assay is expected to be useful as a screening test to differentiate whether or not vitamin K deficiency is present in
T, Meguro, K, Yamada
openaire +2 more sources
Acarboxy Prothrombin (PIVKA-II) as a Marker of Hepatoblastoma in Infants
Journal of Pediatric Gastroenterology and Nutrition, 1987SummaryWe evaluated plasma PIVKA‐II (protein induced by vitamin K absence or antagonist‐II, acarboxy prothrombin) levels in three infants with hepatoblastoma as a tumor marker. PIVKA‐II levels were highly elevated in all three patients. Vitamin K administration, performed in two patients, resulted in only moderate reduction of PIVKA‐II levels ...
K, Motohara +3 more
openaire +2 more sources
One Case of Abnormal Elevation of PIVKA-II
Clinical LaboratoryProtein Induced by Vitamin K Absence or Antagonist II (PIVKA-II) is a serum biomarker that is specifically elevated in hepatocellular carcinoma (HCC) and has important value in early diagnosis, prognosis evaluation, and recurrence prediction of liver cancer.We report a case of extreme elevation of serum PIVKA-II due to the use of warfarin.The patient's
Gangfeng, Li, Tao, Lu, Qiong, Wang
openaire +2 more sources
Synthesis And Catabolism Of Human Prothrombin And Pivka-II
Thrombosis and Haemostasis, 1981The synthesis and catabolism of both prothrombin and PIVKA-II were studied in patients with stable stage of various thromboembolic disorders. Laboratory examinations revealed that their hemostatic and fibrinolytic activities were within normal range.
H Tsukada +6 more
openaire +1 more source
IS PIVKA-II A PROMISING BIOMARKER FOR HEPATOCELLULAR CARCINOMA?
2020Astrakhan Medical Journal, Volume 15, Issue 1, 2020, Pages 6 ...
Broz, Pavel +5 more
openaire +1 more source
Hepatocellular carcinoma: PIVKA-II may be unsuitable for Indian patients
Laboratory MedicineAbstract Introduction Hepatocellular carcinoma (HCC) diagnosis requires a combination of elevated ɑ-fetoprotein (AFP) levels and liver imaging. We evaluated the role of prothrombin induced by vitamin K antagonist-II (PIVKA-II) in patients with suspected HCC.
Dinesh Jothimani +8 more
openaire +2 more sources
Plasma PIVKA-II levels in epileptic patients
Brain and Development, 1990Y, Origuchi +3 more
openaire +2 more sources
[Increased serum PIVKA-II levels in hyperthyroidism].
Rinsho byori. The Japanese journal of clinical pathology, 2002PIVKA-II has been practically used as a tumor marker of hepatocellular carcinoma. On the other hand, increased serum PIVKA-II concentration was reported in a Japanese patient who had hyperthyroidism without liver diseases. To evaluate whether thyroid hormone is related with serum PIVKA-II, we examined serum PIVKA-II concentrations in patients with ...
M, Morimoto +6 more
openaire +1 more source
4780410 Sandwich enzyme immunoassay for PIVKA-II with monoclonal anti-PIVKA-II antibody
Biotechnology Advances, 1989openaire +1 more source

